BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 6, 2026
Home » Authors » Catherine Hollingsworth

Catherine Hollingsworth

Articles

ARTICLES

RegeneRx Secures $5M for Wound Healing Trials

Feb. 28, 2008
By Catherine Hollingsworth

Receptor Logic Finds Partner to Develop T-Cell Mimics

Feb. 28, 2008
By Catherine Hollingsworth

CollaGenex Being Acquired by Galderma for $420M Cash

Feb. 27, 2008
By Catherine Hollingsworth
CollaGenex Pharmaceuticals Inc. said it has agreed to be acquired by a U.S. affiliate of Galderma Pharma SA for about $420 million. (BioWorld Today)
Read More

CollaGenex Being Acquired by Galderma for $420M Cash

Feb. 27, 2008
By Catherine Hollingsworth
CollaGenex Pharmaceuticals Inc. said it has agreed to be acquired by a U.S. affiliate of Galderma Pharma SA for about $420 million. (BioWorld Today)
Read More

GTx Good News on ADT Gives its Stock a 36 Percent Boost

Feb. 26, 2008
By Catherine Hollingsworth

GTx Good News on ADT Gives its Stock a 36 Percent Boost

Feb. 26, 2008
By Catherine Hollingsworth

Repros' Preparing to Launch Phase III Studies of Proellex

Feb. 25, 2008
By Catherine Hollingsworth

Repros' Preparing to Launch Phase III Studies of Proellex

Feb. 25, 2008
By Catherine Hollingsworth

Affomix Closes $7M Series A for Automatic Antibody Effort

Feb. 22, 2008
By Catherine Hollingsworth

Affomix Closes $7M Series A for Automatic Antibody Effort

Feb. 22, 2008
By Catherine Hollingsworth
View All Articles by Catherine Hollingsworth

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 2, 2026.
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • Ontrack Therapeutics divulges compounds for neurodegenerative diseases

    BioWorld Science
    Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
  • IPO puzzle pieces

    Neuracle eyes Shanghai IPO as global BCI funding surges

    BioWorld
    Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
  • Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists

    BioWorld Science
    Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing